SK Chemicals Co., Ltd.

Quick facts

Marketed products

• GNX80 · Other
• Ongentys 50mg

Phase 3 pipeline

• Agrippal S1 · Immunology / Infectious Disease
  Agrippal S1 is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.
• Hepabulin IV · Cardiovascular / Hematology
  Hepabulin IV is a human serum albumin-based therapeutic that delivers heparin conjugate to provide anticoagulant and anti-inflammatory effects.
• NBP606 · Diabetes
  NBP606 is a small molecule that targets the SGLT2 receptor.
• NBP607
  NBP607 is a novel therapeutic agent in development by SK Chemicals, currently in phase 3 clinical trials.
• NBP607-QIV · Immunology / Infectious Disease
  NBP607-QIV is a quadrivalent influenza vaccine designed to provide immunological protection against four strains of influenza virus.
• NBP607-TIV · Immunology / Infectious Disease
  NBP607-TIV is a therapeutic influenza vaccine designed to enhance immune response against multiple influenza virus strains.
• NBP607-V · Endocrinology / Diabetes
  NBP607-V is a recombinant human albumin-fused glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion and reduces glucagon levels to improve glycemic control.
• NBP607-Y · Regenerative Medicine
  NBP607-Y is a dual-acting agent that modulates immune function and promotes tissue regeneration through a novel mechanism.
• NBP608
  NBP608 is a novel therapeutic agent in development by SK Chemicals, currently in phase 3 clinical trials.
• Placebo(For THVD-201)
  Placebo is an inert substance with no active pharmacological mechanism.
• Prodiax-23 · Oncology
  Prodiax-23 is a small molecule that targets the PI3K/AKT pathway.
• Rinexin® Tab · Cardiovascular
  Rinexin is a small molecule that inhibits the renin-angiotensin system.
• S-amlodipine gentisate · Cardiovascular
  S-amlodipine gentisate is a calcium channel blocker that relaxes blood vessels and reduces blood pressure by blocking L-type calcium channels in vascular smooth muscle.
• SID142 · Diabetes
  SID142 is a small molecule that targets the SGLT2 receptor.
• SID530, Taxotere · Oncology
  Taxotere works by inhibiting microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the G2/M phase and apoptosis.
• SK-PC-B70M · Oncology
  SK-PC-B70M is a therapeutic cancer vaccine designed to stimulate immune responses against tumor-associated antigens.
• SKCPT · Diabetes
  SKCPT is a small molecule that targets the SGLT2 receptor.
• THVD-201 · Oncology
  THVD-201 is a therapeutic vaccine designed to stimulate immune responses against human papillomavirus (HPV) for the treatment of HPV-related cancers.

Phase 2 pipeline

• SK-MS10
• SKI3246 High Dose
• SKI3246 Low Dose
• SOTB07

Phase 1 pipeline

• Dapagliflozin and Sitagliptin
• Feburic®
• NBP607QIV
• NBP6081
• NBP6082
• NBP6083
• Renexin®
• SID1903
• SK Antithrombin III
• SKI2670
• TMX-67

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• SK Chemicals Co., Ltd. portfolio CI brief
• SK Chemicals Co., Ltd. pipeline updates RSS